VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
1-Year Return
37.46%
This Quarter Return
+15.01%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$99.9M
AUM Growth
+$2.74M
(+2.8%)
Cap. Flow
-$2.31M
Cap. Flow
% of AUM
-2.32%
Top 10 Holdings %
Top 10 Hldgs %
70.22%
Holding
57
New
9
Increased
16
Reduced
5
Closed
7
Top Buys
| 1 |
Cidara Therapeutics
CDTX
|
+$4.87M |
| 2 |
ALMS
Alumis Inc. Common Stock
ALMS
|
+$4.86M |
| 3 |
Arvinas
ARVN
|
+$3.68M |
| 4 |
Rezolute
RZLT
|
+$1.56M |
| 5 |
Sutro Biopharma
STRO
|
+$1.45M |
Top Sells
| 1 |
SLRN
ACELYRIN
SLRN
|
+$8.32M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$8.19M |
| 3 |
Praxis Precision Medicines
PRAX
|
+$1.5M |
| 4 |
Instil Bio
TIL
|
+$1.2M |
| 5 |
Immunome
IMNM
|
+$1.03M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Immunome
IMNM
$802M
| – | – |
-153,500
| Closed | -$1.03M |
|
|
KRON
52
DELISTED
Kronos Bio
KRON
| – | – |
-35,000
| Closed | -$28.9K |
|
53
Nektar Therapeutics
NKTR
$926M
| – | – |
0
| – | – |
|
|
RGLS
54
DELISTED
Regulus Therapeutics
RGLS
| – | – |
-80,000
| Closed | -$140K |
|
|
SLRN
55
DELISTED
ACELYRIN
SLRN
| – | – |
-3,366,945
| Closed | -$8.32M |
|
|
SWTX
56
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-185,520
| Closed | -$8.19M |
|
|
57
Instil Bio
TIL
$163M
| – | – |
-69,000
| Closed | -$1.2M |
|